| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |